| Kristin Lee Wittenbrook, BA | |
|
Rr 1 Box 256 A, Triadelphia, WV 26059-9725 | |
| (304) 547-9197 | |
| Not Available |
| Full Name | Kristin Lee Wittenbrook |
|---|---|
| Gender | Female |
| Speciality | Counselor - Addiction (substance Use Disorder) |
| Location | Rr 1 Box 256 A, Triadelphia, West Virginia |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1285855221 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101YA0400X | Counselor - Addiction (substance Use Disorder) | (* (Not Available)) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kristin Lee Wittenbrook, BA 1699 Belmont St, Bellaire, OH 43906-1815 Ph: (740) 676-1515 | Kristin Lee Wittenbrook, BA Rr 1 Box 256 A, Triadelphia, WV 26059-9725 Ph: (304) 547-9197 |
News Archive
A multi-national research team that includes a Saint Louis University neurologist has discovered a gene mutation that causes a rare form of Charcot-Marie-Tooth disease, an inherited progressive nerve disorder. The findings are published in an advance online issue of Nature Genetics
A jury in a U.S. District Court in Little Rock, Ark., on Friday dismissed negligence charges in the first of about 5,000 lawsuits filed over Prempro, a combination hormone replacement therapy manufactured by Wyeth, and found the drug's design was not defective, Reuters reports.
Cognizant today announced that it has been selected by TransCelerate BioPharma Inc., a non-profit organization with membership representation from 19 major pharmaceutical companies, to develop a first-of-its-kind, subscription-based platform that will transform the way clinical sites collaborate with pharmaceutical companies on clinical trials.
At a White House ceremony this morning, President Barack Obama signed into law the Senate version of health insurance reform.
A groundbreaking study published in Elsevier's Epilepsy & Behavior provides evidence in mouse model that drugs known as Selective Serotonin Reuptake Inhibitors (SSRIs; one category of antidepressants) may reduce the risk of Sudden Unexpected Death in Epilepsy (SUDEP).
› Verified 6 days ago
Emily Allen, BSW Counselor Medicare: Not Enrolled in Medicare Practice Location: 40 Orrs Ln, Triadelphia, WV 26059 Phone: 304-559-2146 | |
Rebecca Adkins-coss, Counselor Medicare: Not Enrolled in Medicare Practice Location: 40 Orrs Ln, Triadelphia, WV 26059 Phone: 304-559-2146 | |
Lauren Ostapowicz, BA Counselor Medicare: Not Enrolled in Medicare Practice Location: 40 Orrs Ln, Triadelphia, WV 26059 Phone: 304-547-9197 Fax: 304-547-9198 | |
Carrie Sue Haught, MS Counselor Medicare: Not Enrolled in Medicare Practice Location: 40 Orrs Ln, Triadelphia, WV 26059 Phone: 304-559-2146 | |
Taylor Dodson, BSW Counselor Medicare: Not Enrolled in Medicare Practice Location: 40 Orrs Ln, Triadelphia, WV 26059 Phone: 304-547-9197 | |
Chantell Williams, MS Counselor Medicare: Not Enrolled in Medicare Practice Location: 40 Orrs Ln, Triadelphia, WV 26059 Phone: 304-559-2146 |